Generalizability and effect size of the impact of uncontrolled hypertension in patients with type 2 diabetes mellitus

J Clin Hypertens (Greenwich). 2022 May;24(5):660-661. doi: 10.1111/jch.14471. Epub 2022 Mar 21.

Authors

Kristy Bono¹, Dhvani Shihora¹, Anurag Modak^{1

2}

Affiliations

¹ Department of Medicine, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA.
² Center for Advanced Biotechnology and Medicine, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey, USA.

No abstract available

Keywords: ADA guidelines; hypertension; type 2 diabetes mellitus.

Publication types

Letter
Comment

MeSH terms

Antihypertensive Agents / pharmacology
Antihypertensive Agents / therapeutic use
Blood Pressure
Diabetes Mellitus* / drug therapy
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Diabetes Mellitus, Type 2* / epidemiology
Humans
Hypertension* / drug therapy

Substances

Antihypertensive Agents